Calamos Advisors LLC Sells 897 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Calamos Advisors LLC trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 113,656 shares of the company’s stock after selling 897 shares during the quarter. Calamos Advisors LLC’s holdings in GE HealthCare Technologies were worth $8,788,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in GEHC. Barclays PLC purchased a new position in GE HealthCare Technologies during the second quarter worth about $92,462,000. Thrivent Financial for Lutherans purchased a new position in GE HealthCare Technologies during the second quarter worth about $1,590,000. MML Investors Services LLC purchased a new position in GE HealthCare Technologies during the second quarter worth about $929,000. Schonfeld Strategic Advisors LLC purchased a new position in GE HealthCare Technologies during the second quarter worth about $3,474,000. Finally, Tower Research Capital LLC TRC purchased a new position in GE HealthCare Technologies during the second quarter worth about $1,150,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of research reports. Argus upped their price objective on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, April 1st. HSBC initiated coverage on GE HealthCare Technologies in a report on Thursday, February 15th. They issued a “buy” rating and a $100.00 price objective for the company. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and upped their price objective for the stock from $66.00 to $88.00 in a report on Monday, February 12th. Morgan Stanley upped their price objective on GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a report on Monday, February 12th. Finally, Mizuho upped their price objective on GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, April 11th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.09.

GE HealthCare Technologies Trading Down 0.6 %

Shares of GEHC stock opened at $84.49 on Friday. The stock has a market capitalization of $38.56 billion, a PE ratio of 27.98, a P/E/G ratio of 2.96 and a beta of 0.94. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50. The business has a 50-day moving average of $88.74 and a 200 day moving average of $77.82. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.11. The company had revenue of $5.20 billion during the quarter, compared to analysts’ expectations of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. GE HealthCare Technologies’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same period in the prior year, the business posted $1.31 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date of this dividend is Thursday, April 18th. GE HealthCare Technologies’s payout ratio is 3.97%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.